Drug Profile
Research programme: skin and mouth disorders therapy - HealOr
Alternative Names: HO 0202; HO-0210; HO-0408; HO-0409; HO-0709; HO/02/02; HO/02/10; HO/04/08; HO/04/09; HO/07/09Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator HealOr
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acne; Dry skin; Plaque psoriasis; Radiation-induced skin damage; Skin disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in Israel (Topical)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Dry-skin in Israel (Topical)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Plaque-psoriasis in Israel (Topical)